ici 118551 and Hyperplasia

ici 118551 has been researched along with Hyperplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denda, M; Fuziwara, S; Inoue, K1
Heijenbrok, FJ; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA1

Other Studies

2 other study(ies) available for ici 118551 and Hyperplasia

ArticleYear
Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption.
    The Journal of investigative dermatology, 2003, Volume: 121, Issue:1

    Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Clenbuterol; Epidermis; Humidity; Hyperplasia; Male; Mice; Mice, Hairless; Nifedipine; Procaterol; Propanolamines; Verapamil

2003
Beta-adrenergic responses are significantly enhanced in rat carotid artery with intimal hyperplasia.
    Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 362, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carotid Artery Injuries; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Hyperplasia; Imidazoles; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Propanolamines; Rats; Rats, Wistar

2000